NEUROCRINE BIOSCIENCES INC Quarterly Depreciation in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Neurocrine Biosciences Inc quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2024.
  • Neurocrine Biosciences Inc Depreciation for the quarter ending March 31, 2024 was $5.3M, a 29.3% increase year-over-year.
  • Neurocrine Biosciences Inc annual Depreciation for 2023 was $17.8M, a 17.9% increase from 2022.
  • Neurocrine Biosciences Inc annual Depreciation for 2022 was $15.1M, a 38.5% increase from 2021.
  • Neurocrine Biosciences Inc annual Depreciation for 2021 was $10.9M, a 26.7% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5.3M +$1.2M +29.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q1 2023 $4.1M +$800K +24.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q1 2022 $3.3M +$800K +32% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $2.5M +$400K +19% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $2.1M +$500K +31.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $1.6M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.